Breaking News Instant updates and real-time market news.

T

AT&T

$37.20

0.165 (0.45%)

, TWX

Time Warner

$97.16

0.76 (0.79%)

14:55
03/15/18
03/15
14:55
03/15/18
14:55

AT&T-Time Warner merger trial delayed for two days, Reuters says

The trial to assess whether AT&T's (T) purchase of Time Warner (TWX.) conforms to U.S. antitrust law has been delayed due to scheduling issues, says Reuters, citing sources. Reference Link

T

AT&T

$37.20

0.165 (0.45%)

TWX

Time Warner

$97.16

0.76 (0.79%)

  • 24

    Apr

T AT&T
$37.20

0.165 (0.45%)

03/13/18
03/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verizon (VZ), AT&T (T), and T-Mobile (TMUS) were initiated with a Buy at Guggenheim while Sprint (S) was initiated with a Sell. 2. CNO Financial (CNO) initiated with an Outperform at William Blair. 3. GMS Inc. (GMS) initiated with a Buy at Nomura Instinet. 4. Core Laboratories (CLB) assumed with a Neutral at Piper Jaffray. 5. Cutera (CUTR) initiated with an Overweight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/18
GUGG
03/13/18
INITIATION
Target $58
GUGG
Buy
Verizon initiated with a Buy at Guggenheim
Guggenheim analyst Mike McCormack initiated coverage of the Telecom Services space, naming T-Mobile (TMUS) as his Best Idea in the group, but stating that scale remains an advantage in wireless and he is also bullish on AT&T (T) and Verizon (VZ). He started Verizon with a Buy rating and $58 price target.
03/13/18
GUGG
03/13/18
INITIATION
Target $42
GUGG
Buy
AT&T initiated with a Buy at Guggenheim
Guggenheim analyst Mike McCormack initiated coverage of the Telecom Services space, naming T-Mobile (TMUS) as his Best Idea in the group, but stating that scale remains an advantage in wireless and he is also bullish on AT&T (T) and Verizon (VZ). He started AT&T with a Buy rating and $42 price target.
03/12/18
UBSW
03/12/18
UPGRADE
UBSW
Buy
Time Warner upgraded to Buy from Neutral at UBS
UBS analyst John Hodulik upgraded Time Warner (TWX) to Buy with an unchanged price target of $108. While the analyst expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. He sees an "attractive 4-1 risk reward" for Time Warner shares. Hodulik notes the spread to the AT&T offer is 12%, or 35% annualized.
TWX Time Warner
$97.16

0.76 (0.79%)

03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/12/18
RBCM
03/12/18
NO CHANGE
RBCM
Netflix growth and pricing power persist, says RBC Capital
RBC Capital analyst Steven Cahall writes that Netflix is a "gold standard" in content value for consumer, resolving its subscriber issues that alarmed investors just over a year ago. Cahall contends that the company still has growth potential, with estimated 99M Pay TV U.S. household market vs. the company's current 55M U.S. subscriber count. The analyst also points to the "pricing power" of Netflix relative to the competition, stating that the U.S. user engagement of about 124 minutes per day is greater than any other standalone platform and amounts to about $0.003 per watched minute compared to Premium Networks like HBO, Showtime, and Starz are "500%-800% more expensive to watch on a per-minute basis". Moreover, Cahall believes the company is proving itself in the international markets category, where it generated its first positive annual contribution margin in 2017. The analyst estimates that Netflix could have up to $20 in EPS power in the next 5 years, with its stock price rising to as high as $600 per share under a 20-30-times PE valuation.
02/27/18
CHLM
02/27/18
NO CHANGE
Target $50
CHLM
Buy
Nutrisystem price target lowered to $50 from $80 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman lowered his price target for Nutrisystem to $50 from $80, citing guidance below estimates as the company "uncharacteristically" overpaid for pre-bought ads on Fox News (FOXA) & CNN (TWX). The analyst reiterates a Buy rating on Nutrisystem's shares.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$59.38

1.66 (2.88%)

17:06
04/26/18
04/26
17:06
04/26/18
17:06
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says leadership…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EHC

Encompass Health

$57.42

0.06 (0.10%)

17:06
04/26/18
04/26
17:06
04/26/18
17:06
Earnings
Encompass Health raises 2018 adjusted EPS view to $3.30-$3.45 from $3.25-$3.40 »

Consensus for 2018 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 12

    Jun

SBUX

Starbucks

$59.38

1.66 (2.88%)

17:05
04/26/18
04/26
17:05
04/26/18
17:05
Hot Stocks
Starbucks: May 29 store closures 'small piece' of culture change »

Says temporarily store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MBTF

MBT Financial

$10.70

-0.25 (-2.28%)

17:04
04/26/18
04/26
17:04
04/26/18
17:04
Hot Stocks
MBT Financial increases dividend 1c to 7c per share »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

VRSN

VeriSign

$120.93

2.28 (1.92%)

17:04
04/26/18
04/26
17:04
04/26/18
17:04
Earnings
VeriSign narrows FY18 revenue view to $1.20B-$1.215B from $1.195B-$1.215B »

Consensus $1.21B. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EHC

Encompass Health

$57.42

0.06 (0.10%)

17:04
04/26/18
04/26
17:04
04/26/18
17:04
Earnings
Encompass Health reports Q1 adjusted EPS 93c, consensus 81c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 12

    Jun

DKL

Delek Logistics

$29.38

-0.275 (-0.93%)

17:03
04/26/18
04/26
17:03
04/26/18
17:03
Hot Stocks
Delek Logistics boosts quarterly cash distribution to 75c »

Delek Logistics Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

AEM

Agnico Eagle

$43.71

0.42 (0.97%)

17:02
04/26/18
04/26
17:02
04/26/18
17:02
Earnings
Agnico Eagle reports Q1 adjusted EPS 15c, consensus 19c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 01

    May

NUS

Nu Skin

$72.15

0.55 (0.77%)

17:02
04/26/18
04/26
17:02
04/26/18
17:02
Earnings
Nu Skin sees 2018 EPS $3.45-$3.65 with items, consensus $3.62 »

Sees 2018 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MBTF

MBT Financial

$10.70

-0.25 (-2.28%)

17:02
04/26/18
04/26
17:02
04/26/18
17:02
Earnings
Breaking Earnings news story on MBT Financial »

MBT Financial reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

ATR

AptarGroup

$93.28

0.32 (0.34%)

17:02
04/26/18
04/26
17:02
04/26/18
17:02
Earnings
Breaking Earnings news story on AptarGroup »

Aptar sees Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 27

    Jul

  • 26

    Oct

ATR

AptarGroup

$93.28

0.32 (0.34%)

17:01
04/26/18
04/26
17:01
04/26/18
17:01
Earnings
Aptar reports Q1 adjusted EPS 99c, consensus 93c »

Reports Q1 revenue $703M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 27

    Jul

  • 26

    Oct

CBTX

CBTX

$29.13

-0.12 (-0.41%)

17:01
04/26/18
04/26
17:01
04/26/18
17:01
Earnings
Breaking Earnings news story on CBTX »

CBTX reports Q1 EPS 37c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

NUS

Nu Skin

$72.15

0.55 (0.77%)

17:01
04/26/18
04/26
17:01
04/26/18
17:01
Earnings
Nu Skin sees Q2 EPS 86c-91c with items, consensus 91c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SBCF

Seacoast Banking

$27.69

-0.14 (-0.50%)

17:00
04/26/18
04/26
17:00
04/26/18
17:00
Earnings
Seacoast Banking reports Q1 EPS 40c, consensus 39c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 23

    May

NUS

Nu Skin

$72.15

0.55 (0.77%)

17:00
04/26/18
04/26
17:00
04/26/18
17:00
Earnings
Nu Skin reports Q1 EPS 64c with items, consensus 69c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EMN

Eastman Chemical

$105.93

0.835 (0.79%)

16:59
04/26/18
04/26
16:59
04/26/18
16:59
Earnings
Eastman Chemical sees FY18 adjusted EPS growth 10%-14% »

Commenting on the outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

EXPE

Expedia

$106.42

-2 (-1.84%)

16:59
04/26/18
04/26
16:59
04/26/18
16:59
Hot Stocks
Breaking Hot Stocks news story on Expedia »

Expedia expects slower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 04

    Jun

HTBK

Heritage Commerce

$16.78

0.03 (0.18%)

16:58
04/26/18
04/26
16:58
04/26/18
16:58
Earnings
Heritage Commerce reports Q1 EPS 23c, consensus 24c »

Q1 return on average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$105.93

0.835 (0.79%)

16:58
04/26/18
04/26
16:58
04/26/18
16:58
Earnings
Eastman Chemical reports Q1 adjusted EPS $2.23, consensus $2.09 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ENVA

Enova International

$22.60

0.6 (2.73%)

16:57
04/26/18
04/26
16:57
04/26/18
16:57
Earnings
Enova International sees 2018 adjusted EPS $2.10-$2.66, consensus $2.02 »

Sees 2018 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 15

    May

BDX

Becton Dickinson

$232.95

3.43 (1.49%)

16:56
04/26/18
04/26
16:56
04/26/18
16:56
Syndicate
Breaking Syndicate news story on Becton Dickinson »

Becton Dickinson files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 11

    May

  • 14

    May

  • 18

    May

FORR

Forrester

16:56
04/26/18
04/26
16:56
04/26/18
16:56
Earnings
Forrester sees FY18 adjusted EPS $1.38-$1.45, consensus $1.42 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 10

    May

ENVA

Enova International

$22.60

0.6 (2.73%)

16:56
04/26/18
04/26
16:56
04/26/18
16:56
Earnings
Enova International sees Q2 adjusted EPS 41c-62c, consensus 59c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

  • 15

    May

FORR

Forrester

16:55
04/26/18
04/26
16:55
04/26/18
16:55
Earnings
Breaking Earnings news story on Forrester »

Forrester sees Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 10

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.